News - Cyrus Biotech | Molecular Modeling and Design

Use of Cyrus Bench cited in review article of human diseases caused by formin INF2 mutations

July 13, 2020

SEATTLE, WA July 13, 2020 — Cyrus Bench®, Cyrus Biotechnology, Inc.’s SaaS platform for protein engineering, has been used in a recent review article in Cellular and Molecular Life Sciences to correlate computationally predicted alterations in protein stability due to mutation with disease severity (Labat-de-Hoz L, et al. Cell Mol Life Sci. 2020). The formin […]

Prediction of protein mutational free energy: benchmark and sampling improvements increase classification accuracy

March 20, 2020

SEATTLE, WA March 20, 2020 — Software to predict the change in protein stability upon point mutation is a valuable tool for a number of biotechnological and scientific problems. To facilitate the development of such software and provide easy access to the available experimental data, the ProTherm database was created. Biases in the methods and […]

Our Most Recent News

Use of Cyrus Bench cited in review article of human diseases caused by formin INF2 mutations

Prediction of protein mutational free energy: benchmark and sampling improvements increase classification accuracy

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns — (Xconomy)

Cyrus, the Broad team up to make in vivo CRISPR use safer — (FierceBiotech)

Cyrus Biotechnology and CRISPR pioneers team up to boost gene-editing therapies — (GeekWire)

Sitemap

CYRUS SEATTLE